加利福尼亚州提议禁止生物技术公司为安全担忧而与中国做生意。 California proposes banning biotech firms from doing business with China over security fears.

一项新的加利福尼亚法案,即《生物安保法》,要求该州生物技术公司以国家安全关切为由,断绝与中国实体的商业联系。 A new California bill, the Biosecure Act, requires biotechnology companies in the state to sever business ties with Chinese entities, citing national security concerns. 这项立法旨在防止向中国转让敏感的生物技术和数据,反映出对中美技术和科学合作的日益严格审查。 The legislation aims to prevent the transfer of sensitive biological technologies and data to China, reflecting growing scrutiny of China-U.S. tech and scientific collaborations. 该法案目前正在由州立法者审查,可能会影响在加利福尼亚经营的许多生物技术公司。 The bill is currently under review by state lawmakers and could impact numerous biotech firms operating in California.